Cerebral small-vessel disease at high altitude: A comparison of patients from plateau and plain

被引:1
|
作者
Shu, Junlong [1 ,2 ]
Fei, Wen [3 ]
Zhang, Jing [1 ]
Li, Fan [1 ]
Hao, Yu [3 ]
Ding, Zhijie [3 ]
Ji, Shiyong [3 ]
Zhao, Weiwei [3 ]
Hu, Yaxiong [3 ]
Sun, Wei [1 ]
Huang, Yining [1 ,2 ]
Zhao, Yuhua [3 ]
Zhang, Wei [1 ,2 ]
机构
[1] Peking Univ First Hosp, Dept Neurol, Beijing, Peoples R China
[2] Beijing Key Lab Neurovasc Dis Discovery, Beijing, Peoples R China
[3] Peoples Hosp Tibet Autonomous Reg, Dept Neurol, Lhasa, Peoples R China
来源
FRONTIERS IN NEUROLOGY | 2023年 / 14卷
关键词
cerebral small-vessel disease; white matter hyperintensity; plateau; plain; stroke; lacune of presumed vascular origin; WHITE-MATTER HYPERINTENSITIES; OBSTRUCTIVE SLEEP-APNEA; PARTIAL-PRESSURE; STROKE; OXYGEN; TIBET; MRI;
D O I
10.3389/fneur.2023.1086476
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and purposeCerebral small-vessel disease (CSVD) is prevalent worldwide and one of the major causes of stroke and dementia. For patients with CSVD at high altitude, a special environmental status, limited information is known about their clinical phenotype and specific neuroimaging change. We investigated the clinical and neuroimaging features of patients residing at high altitude by comparing with those in the plain, trying to explore the impact of high altitude environment on CSVD. MethodsTwo cohorts of CSVD patients from the Tibet Autonomous Region and Beijing were recruited retrospectively. In addition to the collection of clinical diagnoses, demographic information and traditional vascular risk factors, the presence, location, and severity of lacunes and white matter hyperintensities were assessed by manual counting and using age-related white matter changes (ARWMC) rating scale. Differences between the two groups and influence of long-term residing in the plateau were analyzed. ResultsA total of 169 patients in Tibet (high altitude) and 310 patients in Beijing (low altitude) were enrolled. Fewer patients in high altitude group were found with acute cerebrovascular events and concomitant traditional vascular risk factors. The median (quartiles) ARWMC score was 10 (4, 15) in high altitude group and 6 (3, 12) in low altitude group. Less lacunes were detected in high altitude group [0 (0, 4)] than in low altitude group [2 (0, 5)]. In both groups, most lesions located in the subcortical (especially frontal) and basal ganglia regions. Logistic regressions showed that age, hypertension, family history of stroke, and plateau resident were independently associated with severe white matter hyperintensities, while plateau resident was negatively correlated with lacunes. ConclusionPatients of CSVD residing at high altitude showed more severe WMH but less acute cerebrovascular events and lacunes in neuroimaging, comparing to patients residing at low altitude. Our findings suggest potential biphasic effect of high altitude on the occurrence and progression of CSVD.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] High Circulatory Phosphate Level Is Associated with Cerebral Small-Vessel Diseases
    Chung, Chih-Ping
    Peng, Li-Ning
    Chou, Kun-Hsien
    Liu, Li-Kuo
    Lee, Wei-Ju
    Lin, Ching-Po
    Chen, Liang-Kung
    Wang, Pei-Ning
    TRANSLATIONAL STROKE RESEARCH, 2019, 10 (03) : 265 - 272
  • [42] Small-vessel disease in patients with Parkinson's disease: A clinicopathological study
    Schwartz, Raymond S.
    Halliday, Glenda M.
    Cordato, Dennis J.
    Kril, Jillian J.
    MOVEMENT DISORDERS, 2012, 27 (12) : 1506 - 1512
  • [43] Fibrinogen and the amount of leukoaraiosis in patients with symptomatic small-vessel disease
    Martí-Fàbregas, J
    Valencia, C
    Pujol, J
    García-Sánchez, C
    Martí-Vilalta, JL
    EUROPEAN NEUROLOGY, 2002, 48 (04) : 185 - 190
  • [44] Cerebral Small-Vessel Diseases: A Look Back from 1991 to Today
    Grosset, Lina
    Jouvent, Eric
    CEREBROVASCULAR DISEASES, 2022, 51 (02) : 131 - 137
  • [45] Intracranial arterial dolichoectasia and small-vessel disease in stroke patients
    Pico, F
    Labreuche, J
    Touboul, PJ
    Leys, D
    Amarenco, P
    ANNALS OF NEUROLOGY, 2005, 57 (04) : 472 - 479
  • [46] Neuroprotective effects of oral metformin before stroke on cerebral small-vessel disease
    Akiyama, Natsuki
    Yamashiro, Takayuki
    Ninomiya, Itaru
    Uemura, Masahiro
    Hattori, Yorito
    Ihara, Masafumi
    Onodera, Osamu
    Kanazawa, Masato
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2024, 456
  • [47] Relation of cerebral small-vessel disease and brain atrophy to mild parkinsonism in the elderly
    Reitz, Christiane
    Trenkwalder, Claudia
    Kretzschmar, Konrad
    Roesler, Andreas
    von Eckardstein, Arnold
    Berger, Klaus
    MOVEMENT DISORDERS, 2006, 21 (11) : 1914 - 1919
  • [48] Endothelial nitric oxide gene haplotypes and risk of cerebral small-vessel disease
    Hassan, A
    Gormley, K
    O'Sullivan, M
    Knight, J
    Sham, P
    Vallance, P
    Bamford, J
    Markus, H
    STROKE, 2004, 35 (03) : 654 - 659
  • [49] H-Type Hypertension Is a Risk Factor for Cerebral Small-Vessel Disease
    Li, Tan
    Liu, Xueyun
    Diao, Shanshan
    Kong, Yan
    Duan, Xiaoyu
    Yang, Si
    Liu, Sanjiao
    Fang, Qi
    Cai, Xiuying
    BIOMED RESEARCH INTERNATIONAL, 2020, 2020
  • [50] Blood Neutrophil-to-Lymphocyte Ratio as a Predictor of Cerebral Small-Vessel Disease
    Wang, Yuan
    Ma, Lidan
    Zhang, Meng
    Wei, Jin
    Li, Xuening
    Pan, Xudong
    Ma, Aijun
    MEDICAL SCIENCE MONITOR, 2022, 28